Literature DB >> 17421024

Influence of age on BDNF modulation of hippocampal synaptic transmission: interplay with adenosine A2A receptors.

Maria J Diógenes1, Natália Assaife-Lopes, António Pinto-Duarte, Joaquim A Ribeiro, Ana M Sebastião.   

Abstract

We previously reported that adenosine, through A(2A) receptor activation, potentiates synaptic actions of brain-derived neurotrophic factor (BDNF) in the hippocampus of infant (3-4 weeks) rats. Since A(2A)-receptor-mediated actions are more evident in old than in young rats and since the therapeutic potential for BDNF-based strategies is greater in old subjects, we now evaluated synaptic actions of BDNF and the levels of TrkB receptors and of adenosine A(2A) receptors in the hippocampus of three groups of adult rats: young adults (10-16 weeks), old adults (36-38 weeks), and aged (70-80 weeks), as well as in one group of infant (3-4 weeks) rats. BDNF (20 ng/ml) enhances field excitatory postsynaptic potentials recorded from the hippocampus of young adults and aged rats, an action triggered by adenosine A(2A) receptor activation, since it was blocked by the A(2A) receptor antagonist, ZM 241385. In the other groups of animals BDNF (20 ng/ml) was virtually devoid of action on synaptic transmission. Western blot analysis of receptor density shows decreased amounts of TrkB receptors in old adults and aged rats, whereas A(2A) receptor levels assayed by ligand binding are enhanced in the hippocampus of old adults and aged rats. It is concluded that age-related changes in the density of TrkB receptors and of adenosine A(2A) receptors may be responsible for a nonmonotonous variation of BDNF actions on synaptic transmission in the hippocampus. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17421024     DOI: 10.1002/hipo.20294

Source DB:  PubMed          Journal:  Hippocampus        ISSN: 1050-9631            Impact factor:   3.899


  28 in total

1.  Effects of A₂A adenosine receptor blockade or stimulation on alcohol intake in alcohol-preferring rats.

Authors:  Maria Vittoria Micioni Di Bonaventura; Carlo Cifani; Catia Lambertucci; Rosaria Volpini; Gloria Cristalli; Rino Froldi; Maurizio Massi
Journal:  Psychopharmacology (Berl)       Date:  2011-08-11       Impact factor: 4.530

2.  Caffeine alters proliferation of neuronal precursors in the adult hippocampus.

Authors:  Christian T Wentz; Sanjay S P Magavi
Journal:  Neuropharmacology       Date:  2009-02-13       Impact factor: 5.250

Review 3.  Adenosine hypothesis of schizophrenia--opportunities for pharmacotherapy.

Authors:  Detlev Boison; Philipp Singer; Hai-Ying Shen; Joram Feldon; Benjamin K Yee
Journal:  Neuropharmacology       Date:  2011-02-17       Impact factor: 5.250

Review 4.  Challenges and promises in the development of neurotrophic factor-based therapies for Parkinson's disease.

Authors:  Tiago Martins Rodrigues; André Jerónimo-Santos; Tiago Fleming Outeiro; Ana Maria Sebastião; Maria José Diógenes
Journal:  Drugs Aging       Date:  2014-04       Impact factor: 3.923

5.  Brain-derived neurotrophic factor (BDNF) enhances GABA transport by modulating the trafficking of GABA transporter-1 (GAT-1) from the plasma membrane of rat cortical astrocytes.

Authors:  Sandra H Vaz; Trine N Jørgensen; Sofia Cristóvão-Ferreira; Sylvie Duflot; Joaquim A Ribeiro; Ulrik Gether; Ana M Sebastião
Journal:  J Biol Chem       Date:  2011-10-03       Impact factor: 5.157

6.  Homeostatic control of synaptic activity by endogenous adenosine is mediated by adenosine kinase.

Authors:  Maria José Diógenes; Raquel Neves-Tomé; Sergio Fucile; Katiuscia Martinello; Maria Scianni; Panos Theofilas; Jan Lopatár; Joaquim A Ribeiro; Laura Maggi; Bruno G Frenguelli; Cristina Limatola; Detlev Boison; Ana M Sebastião
Journal:  Cereb Cortex       Date:  2012-09-20       Impact factor: 5.357

7.  Adenosine A1 receptors and microglial cells mediate CX3CL1-induced protection of hippocampal neurons against Glu-induced death.

Authors:  Clotilde Lauro; Raffaela Cipriani; Myriam Catalano; Flavia Trettel; Giuseppina Chece; Valentina Brusadin; Letizia Antonilli; Nico van Rooijen; Fabrizio Eusebi; Bertil B Fredholm; Cristina Limatola
Journal:  Neuropsychopharmacology       Date:  2010-03-03       Impact factor: 7.853

8.  Influence of brain-derived neurotrophic-factor and apolipoprotein E genetic variants on hippocampal volume and memory performance in healthy young adults.

Authors:  Tanja Richter-Schmidinger; Panagiotis Alexopoulos; Marco Horn; Sebastian Maus; Martin Reichel; Cosima Rhein; Piotr Lewczuk; Christos Sidiropoulos; Thomas Kneib; Robert Perneczky; Arnd Doerfler; Johannes Kornhuber
Journal:  J Neural Transm (Vienna)       Date:  2010-12-29       Impact factor: 3.575

9.  GDNF control of the glutamatergic cortico-striatal pathway requires tonic activation of adenosine A receptors.

Authors:  Catarina A R V Gomes; Patrícia F Simões; Paula M Canas; César Quiroz; Ana M Sebastião; Sergi Ferré; Rodrigo A Cunha; Joaquim A Ribeiro
Journal:  J Neurochem       Date:  2009-01-29       Impact factor: 5.372

10.  Tuning and fine-tuning of synapses with adenosine.

Authors:  A M Sebastião; J A Ribeiro
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.